Pembrolizumab monoclonal antibody drug. Targets Programmed cell Death 1 (PD-1) and is used in the treatment of cancer (immune checkpoint inhibitor). G

---

Pembrolizumab monoclonal antibody drug. Targets Programmed cell Death 1 (PD-1) and is used in the treatment of cancer (immune checkpoint inhibitor). Generic name and stylized antibody.

---

Size: 9000px × 4174px
Photo credit: © molekuul.be / Alamy / Afripics
License: Royalty Free
Model Released: No

Keywords: -cell, antibody, biological, biosimilar, biotech, biotechnology, blockade, blocker, cancer, cell, checkpoint, death, disease, drug, immune, immuno-oncology, immunoglobulin, immunology, immunotherapy, infusion, inhibitor, injection, inn, lambrolizumab, lung, lymphocyte, mab, melanoma, metastasis, metastatic, monoclonal, nomenclature, nsclc, pd-1, pembrolizumab, peptide, programmed, protein, receptor